Matos, A.C.; Marques, I.A.; Pires, A.S.; Valentim, A.; Abrantes, A.M.; Botelho, M.F.
The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review. Int. J. Mol. Sci. 2022, 23, 1894.
https://doi.org/10.3390/ijms23031894
AMA Style
Matos AC, Marques IA, Pires AS, Valentim A, Abrantes AM, Botelho MF.
The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review. International Journal of Molecular Sciences. 2022; 23(3):1894.
https://doi.org/10.3390/ijms23031894
Chicago/Turabian Style
Matos, Ana Catarina, Inês Alexandra Marques, Ana Salomé Pires, Ana Valentim, Ana Margarida Abrantes, and Maria Filomena Botelho.
2022. "The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review" International Journal of Molecular Sciences 23, no. 3: 1894.
https://doi.org/10.3390/ijms23031894
APA Style
Matos, A. C., Marques, I. A., Pires, A. S., Valentim, A., Abrantes, A. M., & Botelho, M. F.
(2022). The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review. International Journal of Molecular Sciences, 23(3), 1894.
https://doi.org/10.3390/ijms23031894